T1139 The ACT Trials: Incremental Benefit of Second and Third Induction Doses of Infliximab in Patients with Moderately-to-Severely Active Ulcerative Colitis (UC)

✍ Scribed by Sandborn, William J.; Rutgeerts, Paul J.; Feagan, Brian; Reinisch, Walter; Olson, Allan; Johanns, Jewel R.; Lang, Yinghua (Grace); Rachmilewitz, Daniel; Hanauer, Stephen B.; Lichtenstein, Gary R.; de Villiers, Willem J.; Present, Daniel H.; Sands, Bruce E.; Colombel, Jean-Frédéric

• Book ID: 122565793
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 203 KB
• Volume: 134
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(08)62298-2